IP Library Granted Patent US 9,061,154
Granted Patent B2
US 9,061,154 · App. 14/149,654 · Granted Jun 23, 2015

Systems and methods for adjusting electrical therapy based on impedance changes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,061,154
App. No.
14/149,654
Granted
Jun 23, 2015
Kind
B2
Abstract

System and methods for adjusting electrical therapy based on impedance changes are disclosed herein. A method in accordance with a particular embodiment includes applying a therapeutic electrical signal to a patient via an implanted portion of a patient stimulation system that includes a signal delivery device in electrical communication with a target neural population of the patient. The electrical signal is delivered in accordance with a signal delivery parameter having a first value. Using the implanted portion of the patient stimulation system, a change in an impedance of an electrical circuit that includes the signal delivery device is detected. Based at least in part on the detected impedance change, the method can further include automatically adjusting the value of the signal delivery parameter from the first value to a second value different from the first, without human intervention.

Claims (53)

1. A method for controlling a patient therapy device, comprising:

automatically monitoring an impedance of an electrical circuit that includes an implantable signal delivery device in electrical communication with a target neural population of a patient;

identifying changes in the impedance of the electrical circuit as a function of time;

determining an impedance trend based on identified changes in the impedance; and

automatically adjusting a parameter in accordance with which an electrical signal is delivered via the signal delivery device.

2. The method of claim 1 , wherein determining an impedance trend includes predicting a future value of the impedance.

3. The method of claim 1 wherein the electrical signal is a therapeutic electrical signal, and wherein automatically monitoring an impedance includes automatically monitoring the therapeutic electrical signal delivered via the signal delivery device.

4. The method of claim 1 wherein the electrical signal is a therapeutic electrical signal, and wherein automatically monitoring an impedance includes automatically monitoring a non-therapeutic electrical signal delivered via the signal delivery device.

5. The method of claim 1 wherein automatically adjusting a parameter in accordance with which an electrical signal is delivered includes, based at least in part on the impedance trend, automatically shifting an electrical signal from a first contact to a second contact.

6. A method for controlling a patient therapy device, comprising:

automatically monitoring an impedance of an electrical circuit that includes an implantable signal delivery device in electrical communication with a target neural population Of a patient;

identifying changes in the impedance of the electrical circuit as a function of time;

determining an impedance trend based on identified changes in the impedance, wherein determining an impedance trend includes predicting a future value of the impedance; and

automatically adjusting a compliance margin in accordance with which an electrical signal is delivered via the signal delivery device.

7. A method for controlling a patient therapy device, comprising:

automatically monitoring an impedance of an electrical circuit that includes an implantable signal delivery device in electrical communication with a target neural population of a patient;

identifying changes in the impedance of the electrical circuit as a function of time;

determining an impedance trend based on identified changes in the impedance;

determining whether the impedance trend conforms with a target impedance trend; and

providing a notification when the impedance trend does not conform with the target impedance trend.

8. A method for controlling a patient therapy device, comprising:

applying an electrical signal to a target neural population of a patient via an implanted signal delivery device;

measuring an impedance of an electrical circuit that includes the signal delivery device, wherein measuring an impedance includes measuring an impedance as a function of time;

determining a predicted future value of the impedance; and

automatically adjusting a signal delivery parameter in accordance with which the electrical signal is applied.

9. The method of claim 8 wherein the electrical signal is a therapeutic signal, and wherein measuring an impedance includes measuring an impedance of the electrical signal.

10. The method of claim 8 wherein the electrical signal is a first electrical signal, and wherein the method further comprises:

applying a second electrical signal to the target neural population, wherein the first electrical signal is a therapeutic signal, wherein the second electrical signal is a non-therapeutic signal, and wherein measuring an impedance includes measuring the impedance of the second electrical signal.

11. The method of claim 8 , further comprising:

determining whether the predicted future value conforms with a targeted future value; and

providing a notification when the predicted future value does not conform with the targeted future value.

12. A method for controlling a patient therapy device, comprising:

applying an electrical signal to a target neural population of a patient via an implanted signal delivery device;

measuring an impedance of an electrical circuit that includes the signal delivery device, wherein measuring an impedance includes measuring an impedance as a function of time;

determining a predicted future value of the impedance; and

automatically adjusting a compliance margin in accordance with which the electrical signal is applied.

13. A method for controlling a patient therapy device, comprising:

applying a first electrical signal to a target neural population of a patient via an implanted signal delivery device, wherein the signal delivery device includes a first electrical contact and a second electrical contact;

measuring an impedance of an electrical circuit that includes the signal delivery device, wherein measuring an impedance includes measuring an impedance as a function of time;

determining a predicted future value of the impedance; and

in response to the predicted future value exceeding a targeted future value, applying a second electrical signal via the second electrical contact.

14. A patient therapy system, comprising:

a patient-implantable signal delivery device having an electrical contact positioned to be in electrical communication with a target neural population of a patient when implanted; and

a patient-implantable pulse generator having a computer-readable medium and a processor, wherein the pulse generator is electrically coupleable to the signal delivery device to form an electrical circuit that includes the electrical contact, and wherein the computer-readable medium contains instructions that, when executed;

determine an impedance of the electrical circuit as a function of time;

determine a predicted future value of the impedance; and

based on the determined impedance, adjust a signal delivery parameter for an electrical signal generated by the pulse generator.

15. The system of claim 14 wherein the signal delivery parameter comprises a compliance margin for the electrical signal.

16. The system of claim 14 wherein the electrical contact is a first electrical contact, wherein the signal delivery device includes a second electrical contact, and wherein adjusting a signal delivery parameter includes changing the electrical circuit to exclude the first electrical contact and include the second electrical contact.

17. The system of claim 14 wherein the instructions, when executed:

compare the predicted future value to a targeted future value; and

in response to the predicted future value exceeding the targeted future value, provide a notification to at least one of a practitioner and a patient.

18. The system of claim 14 wherein adjusting a signal delivery parameter includes increasing a strength of the electrical signal.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 031927 FRAME: 0696. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 17, 2016
From: PARKER, JON; WALKER, ANDRE B.; SINGH, UDAI
To: NEVRO CORP.
Reel/Frame 040640/0657 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2014
From: PARKER, JON; WALKER, ANDRE B.; SINGH, UDAI
To: NEVRO CORPORATION
Reel/Frame 031927/0696 →